Literature DB >> 29956096

A case of a maintenance hemodialysis patient with autosomal dominant polycystic kidney disease who underwent living donor liver transplantation alone due to refractory liver cyst infection.

Taro Akihisa1, Ayami Ino1, Hiroto Egawa2, Yoshihito Kotera2, Shunichi Ariizumi2, Akiko Oomori2, Shingo Yamashita2, Yusuke Yamamoto3, Ken Tsuchiya4, Masakazu Yamamoto2, Kosaku Nitta1, Toshio Mochizuki5,6.   

Abstract

Liver cysts are observed in 83% of cases of autosomal dominant polycystic kidney disease (ADPKD). Although not as prevalent as renal cyst infection, liver cyst infection is a serious complication that is sometimes difficult to treat. We report the case of a maintenance hemodialysis patient with ADPKD who received a living donor liver transplantation alone (LDLTA) due to refractory liver cyst infection. The patient was a 67-year-old Japanese man who developed fever and right-side abdominal pain, and liver cyst infection was suspected. Treatment with multiple antibiotics was ineffective. Many liver cysts were observed on magnetic resonance imaging scans and a cyst in liver segment S6, which produced the strongest signal variation, was drained. The fever subsided temporarily, but multiple infected liver cysts were observed on follow-up imaging examination; 4 months later, hepatectomy and LDLTA were performed. Although LDLTA due to refractory liver cyst infection in maintenance hemodialysis patients with ADPKD is risky and should be carefully considered, it may be the only effective treatment.

Entities:  

Keywords:  ADPKD; Hemodialysis; Liver cyst infection; Liver transplantation; Polycystic kidney disease; Polycystic liver disease

Mesh:

Year:  2018        PMID: 29956096      PMCID: PMC6181897          DOI: 10.1007/s13730-018-0348-8

Source DB:  PubMed          Journal:  CEN Case Rep        ISSN: 2192-4449


  29 in total

1.  Extended liver resection for polycystic liver disease can challenge liver transplantation.

Authors:  Béatrice Aussilhou; Ghislaine Douflé; Catherine Hubert; Claire Francoz; Catherine Paugam; Valérie Paradis; Olivier Farges; Valérie Vilgrain; François Durand; Jacques Belghiti
Journal:  Ann Surg       Date:  2010-11       Impact factor: 12.969

2.  Combined liver kidney transplantation: critical analysis of a single-center experience.

Authors:  B Cimsit; M Schilsky; M Moini; K Cartiera; A Arvelakis; S Kulkarni; R Formica; C Caldwell; T Taddei; W Asch; S Emre
Journal:  Transplant Proc       Date:  2011-04       Impact factor: 1.066

3.  Polycystic liver disease: experience at a teaching hospital.

Authors:  Lana Bistritz; Cyrus Tamboli; David Bigam; Vincent G Bain
Journal:  Am J Gastroenterol       Date:  2005-10       Impact factor: 10.864

4.  Pretransplant renal function predicts survival in patients undergoing orthotopic liver transplantation.

Authors:  Satheesh Nair; Sumita Verma; Paul J Thuluvath
Journal:  Hepatology       Date:  2002-05       Impact factor: 17.425

Review 5.  Systematic review: the pathophysiology and management of polycystic liver disease.

Authors:  F Temmerman; L Missiaen; B Bammens; W Laleman; D Cassiman; C Verslype; J van Pelt; F Nevens
Journal:  Aliment Pharmacol Ther       Date:  2011-07-26       Impact factor: 8.171

Review 6.  Cystic disease in women: clinical characteristics and medical management.

Authors:  Arlene B Chapman
Journal:  Adv Ren Replace Ther       Date:  2003-01

7.  Germline mutations in PRKCSH are associated with autosomal dominant polycystic liver disease.

Authors:  Joost P H Drenth; Rene H M te Morsche; Renate Smink; Juan S Bonifacino; Jan B M J Jansen
Journal:  Nat Genet       Date:  2003-02-10       Impact factor: 38.330

8.  Liver transplantation in polycystic liver disease: a relevant treatment modality for adults?

Authors:  Paul S Krohn; Jens G Hillingsø; Preben Kirkegaard
Journal:  Scand J Gastroenterol       Date:  2008-01       Impact factor: 2.423

9.  Magnetic resonance imaging evaluation of hepatic cysts in early autosomal-dominant polycystic kidney disease: the Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease cohort.

Authors:  Kyongtae T Bae; Fang Zhu; Arlene B Chapman; Vicente E Torres; Jared J Grantham; Lisa M Guay-Woodford; Deborah A Baumgarten; Bernard F King; Louis H Wetzel; Philip J Kenney; Marijn E Brummer; William M Bennett; Saulo Klahr; Catherine M Meyers; Xiaoling Zhang; Paul A Thompson; J Philip Miller
Journal:  Clin J Am Soc Nephrol       Date:  2005-10-26       Impact factor: 8.237

10.  Current treatment status of polycystic liver disease in Japan.

Authors:  Koichi Ogawa; Kiyoshi Fukunaga; Tomoyo Takeuchi; Naoki Kawagishi; Yoshifumi Ubara; Masatoshi Kudo; Nobuhiro Ohkohchi
Journal:  Hepatol Res       Date:  2014-01-27       Impact factor: 4.288

View more
  1 in total

1.  Polycystic liver disease with lethal abdominal wall rupture: a case report.

Authors:  Daichi Akuzawa; Yoichiro Uchida; Takuya Ishimura; Hiroko Kakita; Tomomi Endo; Naomi Matsuzaki; Hiroaki Terajima; Tatsuo Tsukamoto
Journal:  J Med Case Rep       Date:  2021-08-03
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.